{"pmid":32275082,"title":"Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.","text":["Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.","The conjunctival mucosa is directly exposed to infectious droplets expelled by patients during close contact and fomites when the eye is touched by contaminated hands.(2, 3) More over, the mucosa of the conjunctiva and upper respiratory tract is connected by nasolacrimal duct, and share the same entry receptor of SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2), on host cell membranes.(2, 3) Hence, it is reasonable to postulate that the conjunctiva may be easily involved in SARS-CoV-2 infection, and may even act as a route of transmission during SARS-CoV-2 infection. This article is protected by copyright. All rights reserved.","J Med Virol","Liu, Zhe","Sun, Chuan-Bin","32275082"],"abstract":["The conjunctival mucosa is directly exposed to infectious droplets expelled by patients during close contact and fomites when the eye is touched by contaminated hands.(2, 3) More over, the mucosa of the conjunctiva and upper respiratory tract is connected by nasolacrimal duct, and share the same entry receptor of SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2), on host cell membranes.(2, 3) Hence, it is reasonable to postulate that the conjunctiva may be easily involved in SARS-CoV-2 infection, and may even act as a route of transmission during SARS-CoV-2 infection. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Liu, Zhe","Sun, Chuan-Bin"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275082","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25859","keywords":["Conjunctiva","Pathogenesis","PathogenesisPatho","genesisPathogene","sPathogenesisPathogenesisRespiratory tractSARS coronavirusTissue tropismVirus classification","sisPathogenesi"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1663712077922959360,"score":7.9164424,"similar":[{"pmid":32094336,"pmcid":"PMC7039956","title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.","text":["High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.","It has been reported that ACE2 is the main host cell receptor of 2019-nCoV and plays a crucial role in the entry of virus into the cell to cause the final infection. To investigate the potential route of 2019-nCov infection on the mucosa of oral cavity, bulk RNA-seq profiles from two public databases including The Cancer Genome Atlas (TCGA) and Functional Annotation of The Mammalian Genome Cap Analysis of Gene Expression (FANTOM5 CAGE) dataset were collected. RNA-seq profiling data of 13 organ types with para-carcinoma normal tissues from TCGA and 14 organ types with normal tissues from FANTOM5 CAGE were analyzed in order to explore and validate the expression of ACE2 on the mucosa of oral cavity. Further, single-cell transcriptomes from an independent data generated in-house were used to identify and confirm the ACE2-expressing cell composition and proportion in oral cavity. The results demonstrated that the ACE2 expressed on the mucosa of oral cavity. Interestingly, this receptor was highly enriched in epithelial cells of tongue. Preliminarily, those findings have explained the basic mechanism that the oral cavity is a potentially high risk for 2019-nCoV infectious susceptibility and provided a piece of evidence for the future prevention strategy in dental clinical practice as well as daily life.","Int J Oral Sci","Xu, Hao","Zhong, Liang","Deng, Jiaxin","Peng, Jiakuan","Dan, Hongxia","Zeng, Xin","Li, Taiwen","Chen, Qianming","32094336"],"abstract":["It has been reported that ACE2 is the main host cell receptor of 2019-nCoV and plays a crucial role in the entry of virus into the cell to cause the final infection. To investigate the potential route of 2019-nCov infection on the mucosa of oral cavity, bulk RNA-seq profiles from two public databases including The Cancer Genome Atlas (TCGA) and Functional Annotation of The Mammalian Genome Cap Analysis of Gene Expression (FANTOM5 CAGE) dataset were collected. RNA-seq profiling data of 13 organ types with para-carcinoma normal tissues from TCGA and 14 organ types with normal tissues from FANTOM5 CAGE were analyzed in order to explore and validate the expression of ACE2 on the mucosa of oral cavity. Further, single-cell transcriptomes from an independent data generated in-house were used to identify and confirm the ACE2-expressing cell composition and proportion in oral cavity. The results demonstrated that the ACE2 expressed on the mucosa of oral cavity. Interestingly, this receptor was highly enriched in epithelial cells of tongue. Preliminarily, those findings have explained the basic mechanism that the oral cavity is a potentially high risk for 2019-nCoV infectious susceptibility and provided a piece of evidence for the future prevention strategy in dental clinical practice as well as daily life."],"journal":"Int J Oral Sci","authors":["Xu, Hao","Zhong, Liang","Deng, Jiaxin","Peng, Jiakuan","Dan, Hongxia","Zeng, Xin","Li, Taiwen","Chen, Qianming"],"date":"2020-02-26T11:00:00Z","year":2020,"_id":"32094336","week":"20209|Feb 24 - Mar 01","doi":"10.1038/s41368-020-0074-x","source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1663352134499827713,"score":115.61745},{"pmid":32127517,"pmcid":"PMC7054527","title":"Transmission routes of 2019-nCoV and controls in dental practice.","text":["Transmission routes of 2019-nCoV and controls in dental practice.","A novel beta-coronavirus (2019-nCoV) caused severe and even fetal pneumonia explored in a seafood market of Wuhan city, Hubei province, China, and rapidly spread to other provinces of China and other countries. The 2019-nCoV was different from SARS-CoV, but shared the same host receptor the human angiotensin-converting enzyme 2 (ACE2). The natural host of 2019-nCoV may be the bat Rhinolophus affinis as 2019-nCoV showed 96.2% of whole-genome identity to BatCoV RaTG13. The person-to-person transmission routes of 2019-nCoV included direct transmission, such as cough, sneeze, droplet inhalation transmission, and contact transmission, such as the contact with oral, nasal, and eye mucous membranes. 2019-nCoV can also be transmitted through the saliva, and the fetal-oral routes may also be a potential person-to-person transmission route. The participants in dental practice expose to tremendous risk of 2019-nCoV infection due to the face-to-face communication and the exposure to saliva, blood, and other body fluids, and the handling of sharp instruments. Dental professionals play great roles in preventing the transmission of 2019-nCoV. Here we recommend the infection control measures during dental practice to block the person-to-person transmission routes in dental clinics and hospitals.","Int J Oral Sci","Peng, Xian","Xu, Xin","Li, Yuqing","Cheng, Lei","Zhou, Xuedong","Ren, Biao","32127517"],"abstract":["A novel beta-coronavirus (2019-nCoV) caused severe and even fetal pneumonia explored in a seafood market of Wuhan city, Hubei province, China, and rapidly spread to other provinces of China and other countries. The 2019-nCoV was different from SARS-CoV, but shared the same host receptor the human angiotensin-converting enzyme 2 (ACE2). The natural host of 2019-nCoV may be the bat Rhinolophus affinis as 2019-nCoV showed 96.2% of whole-genome identity to BatCoV RaTG13. The person-to-person transmission routes of 2019-nCoV included direct transmission, such as cough, sneeze, droplet inhalation transmission, and contact transmission, such as the contact with oral, nasal, and eye mucous membranes. 2019-nCoV can also be transmitted through the saliva, and the fetal-oral routes may also be a potential person-to-person transmission route. The participants in dental practice expose to tremendous risk of 2019-nCoV infection due to the face-to-face communication and the exposure to saliva, blood, and other body fluids, and the handling of sharp instruments. Dental professionals play great roles in preventing the transmission of 2019-nCoV. Here we recommend the infection control measures during dental practice to block the person-to-person transmission routes in dental clinics and hospitals."],"journal":"Int J Oral Sci","authors":["Peng, Xian","Xu, Xin","Li, Yuqing","Cheng, Lei","Zhou, Xuedong","Ren, Biao"],"date":"2020-03-05T11:00:00Z","year":2020,"_id":"32127517","week":"202010|Mar 02 - Mar 08","doi":"10.1038/s41368-020-0075-9","source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1663352134264946691,"score":112.344955},{"pmid":32279064,"title":"Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children.","text":["Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), though primarily a respiratory pathogen, also involves the gastrointestinal tract. Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue. Less than 10% of children with infection develop diarrhea and vomiting. Prolonged RT PCR positivity in the stool has raised the possibility of feco-oral transmission. Elevated transaminases are common, especially in those with severe coronavirus disease-2019 (COVID -19) disease. Children with inflammatory bowel disease and post liver transplant patients do not have an increased risk of disease, and should remain on medications they are already on. Children with chronic liver disease should continue their medications as usual. All elective procedures like endoscopy should be postponed.","Indian Pediatr","Matthai, John","Shanmugam, Naresh","Sobhan, Prasanth","32279064"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), though primarily a respiratory pathogen, also involves the gastrointestinal tract. Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue. Less than 10% of children with infection develop diarrhea and vomiting. Prolonged RT PCR positivity in the stool has raised the possibility of feco-oral transmission. Elevated transaminases are common, especially in those with severe coronavirus disease-2019 (COVID -19) disease. Children with inflammatory bowel disease and post liver transplant patients do not have an increased risk of disease, and should remain on medications they are already on. Children with chronic liver disease should continue their medications as usual. All elective procedures like endoscopy should be postponed."],"journal":"Indian Pediatr","authors":["Matthai, John","Shanmugam, Naresh","Sobhan, Prasanth"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279064","week":"202016|Apr 13 - Apr 19","source":"PubMed","topics":["Transmission","Prevention"],"weight":1,"locations":["ACE-2"],"_version_":1663890921983311872,"score":105.09411},{"pmid":32167153,"title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","text":["Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","A new coronavirus, referred to as SARS-CoV-2, is responsible for the recent outbreak of severe respiratory disease. This outbreak first detected in Wuhan, China in December 2019, has spread to other regions of China and to 25 other countries as of January, 2020. It has been known since the 2003 SARS epidemic that the receptor critical for SARS-CoV entry into host cells is the angiotensin-converting enzyme 2 (ACE2). The S1 domain of the spike protein of SARS-CoV attaches the virus to its cellular receptor ACE2 on the host cells. We thought that it is timely to explain the connection between the SARS-CoV, SARS-CoV-2, ACE2 and the rationale for soluble ACE2 as a potential therapy.","Clin Sci (Lond)","Batlle, Daniel","Wysocki, Jan","Satchell, Karla","32167153"],"abstract":["A new coronavirus, referred to as SARS-CoV-2, is responsible for the recent outbreak of severe respiratory disease. This outbreak first detected in Wuhan, China in December 2019, has spread to other regions of China and to 25 other countries as of January, 2020. It has been known since the 2003 SARS epidemic that the receptor critical for SARS-CoV entry into host cells is the angiotensin-converting enzyme 2 (ACE2). The S1 domain of the spike protein of SARS-CoV attaches the virus to its cellular receptor ACE2 on the host cells. We thought that it is timely to explain the connection between the SARS-CoV, SARS-CoV-2, ACE2 and the rationale for soluble ACE2 as a potential therapy."],"journal":"Clin Sci (Lond)","authors":["Batlle, Daniel","Wysocki, Jan","Satchell, Karla"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32167153","week":"202011|Mar 09 - Mar 15","doi":"10.1042/CS20200163","keywords":["*2019 Novel Coronavirus","*Coronavirus","*angiotensin converting enzyme 2"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1663352134002802688,"score":99.92604},{"pmid":32221306,"pmcid":"PMC7100515","title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.","text":["Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.","Since 2002, beta coronaviruses (CoV) have caused three zoonotic outbreaks, SARS-CoV in 2002-2003, MERS-CoV in 2012, and the newly emerged SARS-CoV-2 in late 2019. However, little is currently known about the biology of SARS-CoV-2. Here, using SARS-CoV-2 S protein pseudovirus system, we confirm that human angiotensin converting enzyme 2 (hACE2) is the receptor for SARS-CoV-2, find that SARS-CoV-2 enters 293/hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are critical for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S. Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions. Further studies using recovered SARS and COVID-19 patients' sera show limited cross-neutralization, suggesting that recovery from one infection might not protect against the other. Our results present potential targets for development of drugs and vaccines for SARS-CoV-2.","Nat Commun","Ou, Xiuyuan","Liu, Yan","Lei, Xiaobo","Li, Pei","Mi, Dan","Ren, Lili","Guo, Li","Guo, Ruixuan","Chen, Ting","Hu, Jiaxin","Xiang, Zichun","Mu, Zhixia","Chen, Xing","Chen, Jieyong","Hu, Keping","Jin, Qi","Wang, Jianwei","Qian, Zhaohui","32221306"],"abstract":["Since 2002, beta coronaviruses (CoV) have caused three zoonotic outbreaks, SARS-CoV in 2002-2003, MERS-CoV in 2012, and the newly emerged SARS-CoV-2 in late 2019. However, little is currently known about the biology of SARS-CoV-2. Here, using SARS-CoV-2 S protein pseudovirus system, we confirm that human angiotensin converting enzyme 2 (hACE2) is the receptor for SARS-CoV-2, find that SARS-CoV-2 enters 293/hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are critical for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S. Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions. Further studies using recovered SARS and COVID-19 patients' sera show limited cross-neutralization, suggesting that recovery from one infection might not protect against the other. Our results present potential targets for development of drugs and vaccines for SARS-CoV-2."],"journal":"Nat Commun","authors":["Ou, Xiuyuan","Liu, Yan","Lei, Xiaobo","Li, Pei","Mi, Dan","Ren, Lili","Guo, Li","Guo, Ruixuan","Chen, Ting","Hu, Jiaxin","Xiang, Zichun","Mu, Zhixia","Chen, Xing","Chen, Jieyong","Hu, Keping","Jin, Qi","Wang, Jianwei","Qian, Zhaohui"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32221306","week":"202014|Mar 30 - Apr 05","doi":"10.1038/s41467-020-15562-9","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1663352135150993410,"score":94.91327}]}